July 23, 2026

Coronal Fracture Reconstruction May Aid Recovery

A randomized trial found greater hip abductor strength recovery with wire augmentation, although overall hip function remained similar.

Conexiant

July 16, 2026

MRI-Based Model May Predict Repairability

In a single-center retrospective study, an internally validated model using radiologist-assessed imaging features and clinical data showed moderate discrimination of arthroscopic meniscal repairability.

Conexiant

July 10, 2026

Can Mecobalamin Prevent Pain Syndrome After Foot and Ankle Surgery?

Postoperative rates of complex regional pain syndrome type 1 and pain and functional outcomes may improve among patients receiving prophylactic mecobalamin following foot and ankle surgery.

Conexiant

July 10, 2026

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Conexiant

July 07, 2026

Robotic TKA Showed No Revision Benefit

High-revision-rate surgeons saw a late revision signal after adopting robotic-assisted total knee arthroplasty, despite no overall reduction in revision rates or failure modes.

Conexiant

July 02, 2026

Transdermal NSAID Matches Oral Celecoxib After Knee Replacement

Randomized trial finds a topical anti-inflammatory patch provided similar pain relief, function, and safety as oral therapy during the first 6 weeks after surgery.

Conexiant

June 25, 2026

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

Conexiant

June 24, 2026

Do Revisions in Rotator Cuff Repair Decline With GLP-1 Use?

Preoperative use was associated with fewer revisions and no increase in short-term complications among patients with obesity, although benefits appeared concentrated in select subgroups.

Conexiant

June 23, 2026

Risks of Mobility Decline After Hip Fracture

Danish registry study found no consistent association between mobility recovery and reoperation, but mortality increased as mobility loss worsened.

Conexiant

June 22, 2026

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

Conexiant